← Accueil actu | Salle du marché
2026-09-16 · Source：deep-www.unite.ai-p15
The Glasgow startup secured £16 million from Scottish Enterprise and £6 million from the UK Government to fuse AI molecular design with robotic synthesis at scale.
Glasgow-based Chemify has secured £22 million ($29.7 million) in grants to scale the infrastructure behind its AI-driven chemistry platform, including the development of its next Chemifarm. The company operates at the intersection of machine learning and laboratory automation, pairing AI-driven molecular design with automated robotic synthesis — a combination that turns computational predictions into physically executed chemical work rather than leaving them as digital outputs.
The funding package splits between two public backers: £16 million from Scottish Enterprise and £6 million from the UK Government. Chemify will deploy the capital to expand a platform built to connect artificial intelligence with the physical world, positioning chemistry as the proving ground for that connection. The dual-source structure ties the company's expansion to both Scottish regional development support and wider UK government backing for AI-linked industrial capability.
The Chemifarm concept sits at the core of the growth plan. These robotic facilities execute molecules designed by Chemify's AI through automated synthesis, replacing conventional manual laboratory workflows with repeatable machine-run chemistry. By building its next Chemifarm, the company is adding dedicated infrastructure for running software-generated molecular designs through robotic pipelines at greater scale — the step it argues is necessary to move AI-designed chemistry from experiment to dependable production capability.
For readers tracking AI infrastructure beyond conventional data centers, Chemify's raise illustrates how AI systems are extending into laboratory robotics, where molecular design workloads and automated physical execution converge. The £22 million commitment from public sources gives the Glasgow firm the resources to test whether AI-orchestrated chemistry can scale into industrial-grade infrastructure, with the next Chemifarm serving as the visible test case for that thesis.
The deal also signals continued public-sector willingness to fund companies merging AI software with physical automation, a category increasingly viewed as strategic. Chemify now carries the mandate — and the money — to demonstrate that its chemistry-farm model can grow beyond a single facility.
Mots-clés: Chemify · Chemifarm · AI Chemistry · Robotic Synthesis · Lab Automation · Scottish Enterprise
萬安算交所 AIXX · AIXX · Bourse compute vérifiée · Accéder à la salle